-
M23 militia says to pull out of key DR Congo city at US's request
-
Thousands of glaciers to melt each year by mid-century: study
-
China to impose anti-dumping duties on EU pork for five years
-
Nepal starts tiger census to track recovery
-
Economic losses from natural disasters down by a third in 2025: Swiss Re
-
Indonesians reeling from flood devastation plea for global help
-
Timeline: How the Bondi Beach mass shooting unfolded
-
On the campaign trail in a tug-of-war Myanmar town
-
Bondi Beach suspect visited Philippines on Indian passport
-
Kenyan girls still afflicted by genital mutilation years after ban
-
Djokovic to warm up for Australian Open in Adelaide
-
Man bailed for fire protest on track at Hong Kong's richest horse race
-
Men's ATP tennis to apply extreme heat rule from 2026
-
10-year-old girl, Holocaust survivors among Bondi Beach dead
-
Steelers edge towards NFL playoffs as Dolphins eliminated
-
Australian PM says 'Islamic State ideology' drove Bondi Beach gunmen
-
Canada plow-maker can't clear path through Trump tariffs
-
Bank of Japan expected to hike rates to 30-year high
-
Cunningham leads Pistons past Celtics
-
Stokes tells England to 'show a bit of dog' in must-win Adelaide Test
-
EU to unveil plan to tackle housing crisis
-
EU set to scrap 2035 combustion-engine ban in car industry boost
-
Australian PM visits Bondi Beach hero in hospital
-
'Easiest scam in the world': Musicians sound alarm over AI impersonators
-
'Waiting to die': the dirty business of recycling in Vietnam
-
Asian markets retreat ahead of US jobs as tech worries weigh
-
Famed Jerusalem stone still sells despite West Bank economic woes
-
Trump sues BBC for $10 billion over documentary speech edit
-
Chile follows Latin American neighbors in lurching right
-
Will OpenAI be the next tech giant or next Netscape?
-
Khawaja left out as Australia's Cummins, Lyon back for 3rd Ashes Test
-
Australia PM says 'Islamic State ideology' drove Bondi Beach shooters
-
Scheffler wins fourth straight PGA Tour Player of the Year
-
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
-
Security beefed up for Ashes Test after Bondi shooting
-
Wembanyama blocking Knicks path in NBA Cup final
-
Amorim seeks clinical Man Utd after 'crazy' Bournemouth clash
-
Man Utd blow lead three times in 4-4 Bournemouth thriller
-
Stokes calls on England to 'show a bit of dog' in must-win Adelaide Test
-
Trump 'considering' push to reclassify marijuana as less dangerous
-
Chiefs coach Reid backing Mahomes recovery after knee injury
-
Trump says Ukraine deal close, Europe proposes peace force
-
French minister urges angry farmers to trust cow culls, vaccines
-
Angelina Jolie reveals mastectomy scars in Time France magazine
-
Paris Olympics, Paralympics 'net cost' drops to 2.8bn euros: think tank
-
Chile president-elect dials down right-wing rhetoric, vows unity
-
Five Rob Reiner films that rocked, romanced and riveted
-
Rob Reiner: Hollywood giant and political activist
-
Observers say Honduran election fair, but urge faster count
-
Europe proposes Ukraine peace force as Zelensky hails 'real progress' with US
New Zealand approves medicinal use of 'magic mushrooms'
New Zealand on Wednesday approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called "magic mushrooms".
Deputy Prime Minister David Seymour said rules had been relaxed so psilocybin could be used to treat certain types of depression.
Psilocybin is a naturally occurring psychedelic compound found in some species of mushroom and can cause hallucinations and an altered state of mind.
"Psilocybin remains an unapproved medicine, but a highly experienced psychiatrist has been granted authority to prescribe it to patients with treatment-resistant depression," Seymour said.
"This is huge for people with depression who've tried everything else and are still suffering.
"If a doctor believes psilocybin can help, they should have the tools to try."
There will be tight rules for prescribing the drug.
Only psychiatrists who have been involved in psilocybin clinical trials will be allowed to prescribe it, and they must strictly report its use and keep detailed records.
Party drugs such as as MDMA and magic mushrooms are increasingly being used in mainstream medical settings, helping treat post-traumatic stress disorder and depression.
Australia approved the medicinal use of psilocybin in 2023.
X.Brito--PC